Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
| Paricalcitol Reduced Residual Renal Risk in Diabetic Nephropathy Patients - Internal Medicine News Digital Network |
|
|
|
Internal Medicine News Digital NetworkSelective vitamin D receptor activation with paricalcitol lowers residual albuminuria and could provide renal protection in patients with diabetic ...Vitamin-D analog could lower renal risk in diabetic nephropathy TheHeart.OrgParicalcitol Reduces Residual Albuminuria in Patients With Type 2 Diabetic ... read more |
Professional dialysis recruitment

